Viz.ai Unveils AI-Powered Software for 3D CTA Neurovascular Imaging
Offering automated conversion of computed tomography angiography (CTA) into 3D images, Viz 3D CTA reportedly facilitates real-time insights into complex neurovascular anatomy.
While traditional neurovascular imaging poses challenges with manual 3D renderings, limited spatial context and difficulty in visualizing more distal vessel abnormalities, the launch of the artificial intelligence (AI) software Viz 3D CTA may provide a viable alternative.
Providing automated conversion of computed tomography angiography (CTA) scans into high-resolution 3D views in minutes, the Viz 3D CTA software enhances diagnostic clarity and efficiency, according to Viz.ai, the developer of the software.
The newly launched Viz 3D CTA software provides automated conversion of computed tomography angiography (CTA) scans into real-time, high-resolution 3D views of neurovascular anatomy, according to Viz.ai, the developer of the software. (Image courtesy of Viz.ai .)
The company said key attributes of Viz 3D CTA include skull-stripped views, automated post-processing and interactive tools including sagittal and axial rotation.
“Viz 3D CTA gives me a clearer, faster view of what’s going on. Being able to rotate the image and see vessels from different angles makes a big difference, especially in tricky areas,” said Benjamin Alwood, M.D., an assistant professor of vascular neurology at the University of Florida. “It’s also a great safety net for spotting occlusions that might otherwise be missed. Having this kind of clarity right away helps me make quicker, more confident decisions.”
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
